Numerous studies have shown that women who use the antidepressant Zoloft (sertraline) during pregnancy are more likely to have a baby with a heart defect or other serious birth defect.

What is the problem?

Zoloft (sertraline) is a popular antidepressant medication manufactured by Pfizer. It belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRI), which treat psychological disorders by influencing serotonin in the brain.

When a pregnant woman uses Zoloft, it passes through the placenta and to a developing baby. No one knows exactly how Zoloft influences fetal development, but a number of studies have linked first-trimester use of Zoloft with an increased risk of heart defects. When Zoloft is used late in pregnancy, it is associated with a higher risk of Persistent Pulmonary Hypertension of the Newborn (PPHN), fetal withdrawal, and other life-threatening complications.

Zoloft Class Action Information

Over 600 lawsuits have been filed, but these are not part of a Zoloft class action. Instead, they are individual legal claims. Approximately 589 are centralized in a Multi-District Litigation (MDL No. 2342) in the U.S. District Court for the Eastern District of Pennsylvania. Dozens of additional claims are pending in courts around the nation, including Alabama, California, Illinois, Missouri, and New York.